2021
|
Invention
|
Use of isovaleryl spiramycin compound or composition thereof in preparation of medicament for tre... |
|
Invention
|
Isovaleryl spiramycin compound or application of isovaleryl spiramycin composition in preparation... |
|
Invention
|
Application of isovalerylspiramycin compound and composition thereof in preparation of antiviral ... |
2020
|
Invention
|
Target for screening anti-tumor drug, use thereof and screening method therefor.
Disclosed are t... |
|
Invention
|
Target for screening anti-tumor drug, use thereof and screening method therefor. Disclosed are a ... |
|
Invention
|
Novel compound and pharmaceutical composition. The present invention belongs to the field of phar... |
|
Invention
|
Medicament and combination product used for preventing, alleviating and/or treating fibrosis, and... |
|
Invention
|
Drug and combination product used for prevention, alleviation and/or treatment of fibrosis, and u... |
|
Invention
|
Use of acylated spiramycin in preparation of medicament for treating coronavirus infectious disea... |
2019
|
Invention
|
Spiramycin-producing strain, carrimycin-producing strain, construction method therefor, use there... |
|
Invention
|
Spiramycin-producing strain, kelimycin-producing strain, construction method therefor, use thereo... |
|
Invention
|
Drug used for preventing and/or treating pain and/or fever, combination product, and use thereof.... |
|
Invention
|
Mtor inhibitor, pharmaceutical composition and use thereof.
Disclosed are an mTOR inhibitor, a p... |
|
Invention
|
Use of carrimycin or active ingredients thereof and use thereof. A medicament for preventing and/... |
|
Invention
|
Mtor inhibitor, pharmaceutical composition and use thereof. Disclosed are an mTOR inhibitor, a ph... |
|
Invention
|
Use of carrimycin or active ingredient thereof. A drug for preventing and/or treating diseases. T... |
2018
|
Invention
|
Use of isovaleryl spiramycin i, ii and/or iii in manufacturing medicament for treating and/or pre... |
|
Invention
|
Use of isovalerylspiramycin i, ii and/or iii in preparation of drug for treating and/or preventin... |
|
Invention
|
Use of carrimycin and pharmaceutically acceptable salts of carrimycin in manufacturing medicament... |
|
Invention
|
Use of carrimycin and pharmaceutically acceptable salt thereof for manufacture of medicament for ... |
2016
|
Invention
|
Mycobacterium tuberculosis infection resistance. Bacillus infected diseases are expected to be de... |
|
Invention
|
Applications of kelimycin in mycobacterium tuberculosis infection resistance. Applications of kel... |
|
Invention
|
Biosynthetic gene cluster of carrimycin. The present disclosure provides a biosynthetic gene clus... |
|
Invention
|
Carrimycin biosynthetic gene cluster. Provided is a carrimycin biosynthetic gene cluster, compris... |
2011
|
Invention
|
Levocarrimycin, pharmaceutical compositions, preparation methods and uses thereof. D=−52°˜−57° in... |
|
Invention
|
Levoisovalerylspiramycin i, ii or iii, preparations, preparation methods and uses thereof. Disclo... |